Create an account, provide basic information, and schedule your online consultation with a licensed holistic health doctor.
Use our secure telemedicine video platform to discuss your health concerns from the comfort of your home.
After your consultation, your doctor will create a personalized treatment plan based on your needs.
Our care team will explain all the medication options and help you make the right decision for your weight loss goals.
Ozempic has become a breakthrough in weight loss treatment. It works as an injection that mimics a hormone targeting areas of the brain responsible for appetite control. Ozempic supports significant weight loss by reducing hunger and calorie intake.
This approach helps manage blood sugar levels while promoting weight loss.
Ozempic was approved by the FDA in 2017 for type 2 diabetes. It may be prescribed off-label for weight loss by a licensed medical provider.
Ozempic is injected once a week and works by mimicking a hormone called GLP-1 (glucagon-like peptide-1). This regulates blood sugar and appetite and helps lower A1C.
Ozempic comes in different dosages and forms to meet different medical needs and treatment plans. The medication is available in pre-filled dosage pens. Common dosages include 0.5 mg, 1 mg, 2 mg, and a 2.4 mg dose for weight loss.
Note: Healthcare providers prescribe Ozempic dosages based on a patient’s health condition, weight loss goals, and response to treatment. For weight loss in non-diabetic patients, doctors often start with a lower dose and increase it to a maximum dose, depending on the patient’s tolerance and progress.
Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Check more of the safety guidelines for Ozempic here.
Risk of thyroid C−cell tumors
• In rodents, semaglutide causes thyroid C-cell tumors. It is unknown whether
OZEMPIC® causes thyroid C-cell tumors, including medullary thyroid
carcinoma (MTC), in humans as the human relevance of semaglutide-induced
rodent thyroid C-cell tumors has not been determined (5.1, 13.1).
• OZEMPIC® is contraindicated in patients with a personal or family history of
MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN
2). Counsel patients regarding the potential risk of MTC and symptoms of
thyroid tumors (4, 5.1).
Most side effects of Ozempic are mild and tend to resolve as your body adjusts to the medication. But it’s still important to be aware of possible reactions.
Nausea: Most common side effect, especially when starting the medication or increasing the dose.
Diarrhea: Some people may experience gastrointestinal discomfort, including diarrhea or constipation.
Vomiting: A small percentage of users report vomiting, especially at the start of treatment.
Fatigue: Feeling tired or lethargic can occur, but this usually improves over time.
Most side effects, such as nausea or gastrointestinal discomfort, improve over time.
To reduce the likelihood of these issues, your healthcare provider may start you on a lower dose and gradually increase it.
Limit or avoid alcohol while taking Ozempic. Alcohol can affect blood sugar levels and may increase the risk of side effects associated with the medication.
Avoid using Ozempic during pregnancy, as it may pose risks to the fetus. If you are pregnant or planning to become pregnant, talk to your healthcare provider about safer treatment options.
Ozempic can interact with other medications, including over-the-counter drugs and herbal supplements. Inform your healthcare provider about all medications you are taking to prevent potential drug interactions.
A GLP-1 receptor agonist that helps with weight loss by reducing appetite, slowing digestion, and improving metabolic health.
A higher-dose semaglutide injection approved specifically for weight loss, helping patients achieve significant and sustained results. Approved by the FDA for weight loss.
A dual-acting GLP-1 and GIP receptor agonist that promotes weight loss by suppressing appetite and improving metabolic function.
An injectable medication with tirzepatide that targets diabetes management and significant weight reduction as a secondary benefit.
A tirzepatide-based medication designed specifically for weight loss, offering enhanced appetite control and metabolic improvements. Approved by the FDA for weight loss.
An oral semaglutide tablet that supports weight loss by reducing appetite and calorie intake while managing blood sugar levels. Not FDA-approved for weight loss.
A combination of naltrexone and bupropion that addresses hunger and cravings, offering a dual-action approach to weight management.
Ozempic is an FDA-approved medication that contains semaglutide. It is primarily used to manage type 2 diabetes and also supports weight loss as a secondary benefit.
Ozempic mimics the GLP-1 hormone, which regulates blood sugar levels, reduces appetite, slows digestion, and decreases calorie intake.
No, Ozempic is FDA-approved for type 2 diabetes management, but weight loss is a secondary benefit. Wegovy, another semaglutide-based drug, is FDA-approved for weight loss.
Coverage depends on your insurance plan. Contact your provider to confirm coverage for Ozempic under diabetes treatment or weight management.
The number of doses depends on the pen and prescribed dose. For example, a 1 mg pen typically contains four weekly doses at 0.25 mg or two doses at 0.5 mg.
Ozempic reduces appetite, increases feelings of fullness, and slows digestion, leading to lower calorie intake and gradual weight loss.
**This medication is FDA-approved for [Type 2 Diabetes] and may be prescribed off-label for weight loss by a licensed medical provider.**
Ozempic is generally safe when used as prescribed. However, it may cause side effects, so consult your healthcare provider to determine if it’s right for you.
Consult a licensed healthcare provider for a prescription. They will evaluate your medical history and determine if Ozempic is appropriate for your weight loss goals.
**This medication is FDA-approved for [Type 2 Diabetes], and may be prescribed off-label for weight loss by a licensed medical provider.**
You can stay on Ozempic as long as your healthcare provider deems it necessary for your diabetes or weight management. Regular follow-ups are recommended.
Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite. Serious side effects may include pancreatitis or thyroid issues.
Inject Ozempic under the skin in the abdomen, thigh, or upper arm. Rotate injection sites each time.
Avoid high-fat, greasy, or sugary foods, as they can worsen gastrointestinal side effects like nausea.
You can use Ozempic and alcohol together, but alcohol may affect blood sugar levels. Drink in moderation and monitor your blood sugar closely.
No, Ozempic is not recommended during pregnancy or breastfeeding due to potential risks to the baby.
No, Ozempic is not approved for use in individuals under 18 years of age.